Literature DB >> 11059533

Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease.

Y Kuramochi1, T Ohkubo, N Takechi, D Fukumi, Y Uchikoba, S Ogawa.   

Abstract

BACKGROUND: We studied the mechanism of thrombus formation in coronary aneurysms based on rheological findings.
METHODS: We studied 43 coronary aneurysms in 33 patients with Kawasaki disease (mean (+/- SD) age 6.1 +/- 4.3 years). These lesions were divided into three groups on the basis of maximum diameter: (i) small (group S); (ii) medium sized (group M); and (iii) large (group L) aneurysms. Using a Doppler flow guidewire and a pressure-monitoring guidewire, we measured coronary flow velocity and perfusion pressure inside aneurysms and in adjacent normal-looking vessels. We calculated the average peak velocity (APV) index, the mean coronary perfusion pressure (P) index and shear index.
RESULTS: The APV index and shear index decreased significantly (p < 0.005) as the aneurysm size increased (APV index in groups S, M and L was 0.893 +/- 0.149, 0.573 +/- 0.242 and 0.128 +/- 0.131, respectively; shear index in groups S, M and L was 0.750 +/- 0.149, 0.328 +/- 0.153 and 0.020 +/- 0.028, respectively). However, coronary perfusion pressure showed no relationship to aneurysm size and was not significantly different from that in adjacent normal-looking vessels.
CONCLUSIONS: The results of the present study suggest that the stagnation of flow and the reduction of shear stress in coronary aneurysms could initiate thrombus formation.

Entities:  

Mesh:

Year:  2000        PMID: 11059533     DOI: 10.1046/j.1442-200x.2000.01270.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  13 in total

1.  Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Computerized Tomography Angiograms.

Authors:  Noelia Grande Gutierrez; Olga Shirinsky; Nina Gagarina; Galina Lyskina; Ryuji Fukazawa; Shunichi Ogawa; Jane C Burns; Alison L Marsden; Andrew M Kahn
Journal:  Am J Cardiol       Date:  2017-05-30       Impact factor: 2.778

2.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

3.  Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.

Authors:  Cedric Manlhiot; Kyle Millar; Fraser Golding; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2009-12-19       Impact factor: 1.655

4.  Low-dose antithrombotic treatment in coronary thrombosis of Kawasaki disease.

Authors:  Hua Peng; Zubo Wu; Yalan Liu; Ling Li; Shuangshuang Kong; Jing Wu; Yali Liu
Journal:  Pediatr Cardiol       Date:  2014-10-09       Impact factor: 1.655

5.  Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal.

Authors:  Sophie Alloul; Nagib Dahdah; Joaquim Miró
Journal:  Pediatr Cardiol       Date:  2008-07-30       Impact factor: 1.655

6.  Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions.

Authors:  Fabienne Mueller; Walter Knirsch; Paul Harpes; René Prêtre; Emanuela Valsangiacomo Buechel; Oliver Kretschmar
Journal:  Clin Res Cardiol       Date:  2009-06-05       Impact factor: 5.460

7.  Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.

Authors:  Yunjia Tang; Wenhua Yan; Ling Sun; Qiuqin Xu; Yueyue Ding; Haitao Lv
Journal:  Clin Rheumatol       Date:  2018-01-12       Impact factor: 2.980

8.  Hemodynamic variables in aneurysms are associated with thrombotic risk in children with Kawasaki disease.

Authors:  Noelia Grande Gutierrez; Mathew Mathew; Brian W McCrindle; Justin S Tran; Andrew M Kahn; Jane C Burns; Alison L Marsden
Journal:  Int J Cardiol       Date:  2019-01-28       Impact factor: 4.164

Review 9.  Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Authors:  Nagib Dahdah; Anne Fournier
Journal:  Diagnostics (Basel)       Date:  2013-01-10

10.  Two cases of super-giant coronary aneurysms after kawasaki disease.

Authors:  Joowon Lee; Gi Beom Kim; Bo Sang Kwon; Eun Jung Bae; Chung Il Noh
Journal:  Korean Circ J       Date:  2014-01-14       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.